Virtus ETF Advisers LLC Ardelyx, Inc. Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 66,728 shares of ARDX stock, worth $355,660. This represents 0.15% of its overall portfolio holdings.

Number of Shares

66,728

Previous 50,747 31.49%

Holding current value

$355,660

Previous $349,000 1.43%

% of portfolio

0.15%

Previous 0.17%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.49 - $6.85 $71,754 - $109,469	15,981 Added 31.49%	66,728 $344,000
Q2 2024 Aug 14, 2024	BUY	$5.89 - $9.31 $210,903 - $333,363	35,807 Added 239.67%	50,747 $376,000
Q1 2024 May 15, 2024	SELL	$6.05 - $9.74 $6,183 - $9,954	-1,022 Reduced 6.4%	14,940 $109,000
Q4 2023 Feb 15, 2024	SELL	$3.29 - $6.64 $28,402 - $57,323	-8,633 Reduced 35.1%	15,962 $98,000
Q3 2023 Nov 07, 2023	SELL	$3.3 - $4.83 $8,098 - $11,852	-2,454 Reduced 9.07%	24,595 $100,000
Q2 2023 Aug 14, 2023	BUY	$3.23 - $4.95 $87,368 - $133,892	27,049 New	27,049 $91,000
Q4 2021 Feb 14, 2022	SELL	$0.86 - $1.7 $24,676 - $48,779	-28,694 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$1.27 - $8.17 $1,896 - $12,197	-1,493 Reduced 4.95%	28,694 $38,000
Q2 2021 Aug 10, 2021	SELL	$6.55 - $8.98 $88,176 - $120,888	-13,462 Reduced 30.84%	30,187 $229,000
Q1 2021 May 17, 2021	BUY	$6.1 - $7.69 $4,690 - $5,913	769 Added 1.79%	43,649 $289,000
Q4 2020 Feb 12, 2021	SELL	$5.05 - $7.1 $19,669 - $27,654	-3,895 Reduced 8.33%	42,880 $277,000
Q3 2020 Nov 13, 2020	SELL	$5.25 - $7.08 $33,516 - $45,198	-6,384 Reduced 12.01%	46,775 $246,000
Q2 2020 Aug 05, 2020	BUY	$5.37 - $8.11 $9,666 - $14,597	1,800 Added 3.5%	53,159 $368,000
Q1 2020 May 14, 2020	SELL	$4.35 - $8.79 $32,594 - $65,863	-7,493 Reduced 12.73%	51,359 $292,000
Q4 2019 Feb 13, 2020	BUY	$4.23 - $8.29 $248,943 - $487,883	58,852 New	58,852 $442,000

Others Institutions Holding ARDX

# of Institutions

233

Shares Held

150M

Call Options Held

1.54M

Put Options Held

3.08M

View Full List

About ARDELYX, INC.

Ticker ARDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 154,636,000
Market Cap $824M
Description
Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...

More about ARDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Ardelyx, Inc. Transaction History